Management of Bleeding in Patients with Uterine Mass

Immediate Assessment and First-Line Medical Management

The American College of Radiology recommends starting with first-line medical therapy using combined hormonal contraceptives, levonorgestrel IUD, or tranexamic acid to control bleeding while simultaneously correcting anemia with iron supplementation 1, 2
Patients ≥35 years old, with risk factors for endometrial cancer, or with endometrial thickening >1.5 cm should undergo endometrial biopsy to rule out hyperplasia or malignancy, as suggested by the American Family Physician 3, 2
The American Family Physician also recommends performing a pregnancy test to exclude pregnancy-related bleeding 3
Checking thyroid function and prolactin levels is necessary as thyroid dysfunction and hyperprolactinemia commonly cause abnormal bleeding, according to the American Family Physician 3
Obtaining a pelvic ultrasound (transvaginal preferred) is recommended to characterize fibroid size, number, and location, as per the Praxis Medical Insights 2

The most effective first-line treatment for reducing menstrual blood loss is the levonorgestrel-releasing IUD, as stated by the Praxis Medical Insights 1
Combined hormonal contraceptives are particularly effective for women with small fibroids, according to the Journal of the American College of Radiology 4, 1
Tranexamic acid is an important nonhormonal alternative that significantly reduces menstrual blood loss, especially when hormonal options are contraindicated or not desired, as recommended by the Journal of the American College of Radiology and the Praxis Medical Insights 4, 1
NSAIDs are effective for pain control and modest reduction in bleeding, as per the Praxis Medical Insights 1

GnRH antagonists with hormone add-back therapy reduce both bleeding symptoms and fibroid volume more effectively than first-line options, as stated by the Praxis Medical Insights 1, 2
Combination low-dose estrogen/progestin add-back therapy mitigates hypoestrogenic side effects while maintaining efficacy, according to the Praxis Medical Insights 1, 2
GnRH agonists are effective for reducing bleeding and fibroid volume but require add-back therapy to prevent bone mineral density loss with prolonged use, as recommended by the Journal of the American College of Radiology and the Praxis Medical Insights 4, 1

Hysteroscopic myomectomy is recommended for submucosal fibroids, as per the Praxis Medical Insights 2
Laparoscopic or open myomectomy is suggested for intramural or subserosal fibroids, though recurrence rates range 23-33%, according to the Journal of the American College of Radiology and the Praxis Medical Insights 5, 2
Uterine artery embolization achieves >50% reduction in fibroid size at 5 years with shorter hospital stay and decreased blood loss compared to surgery, but has higher reintervention rates, as stated by the Journal of the American College of Radiology and the Praxis Medical Insights 5, 4, 2
Hysterectomy is the most definitive treatment with significantly better long-term quality of life compared to other options, as recommended by the Journal of the American College of Radiology 5, 4

Preoperative GnRH agonists/antagonists for 3 months can reduce fibroid size and correct anemia before surgery, as suggested by the Praxis Medical Insights 1, 2
Concurrent iron supplementation during medical therapy is recommended, according to the Praxis Medical Insights 2